Literature DB >> 2219575

Transrectal ultrasonography for the early detection and staging of prostate cancer.

A D Hernandez1, J A Smith.   

Abstract

Relatively recent changes and improvements in equipment have vastly increased image resolution for transrectal ultrasonography of the prostate. The expanded use of transrectal ultrasonography has greatly furthered knowledge of prostate zonal anatomy and permitted clinical evaluation of internal prostate architecture. The technique is operator dependent, as the quality of the results is related directly to that person's knowledge and experience. The significant majority of prostate cancers originate from the peripheral zone. Palpable stage B nodules characteristically have a hypoechoic appearance. There is disagreement about the tumor characteristics that cause hypoechogenicity, but large tumors may obscure the normal prostate anatomy and appear isoechoic because of the lack of contrast with surrounding prostate tissue. The transition zone of the prostate is the origin of benign prostatic hyperplasia and almost 20 per cent of prostate cancers. These tumors probably correspond to most stage A lesions. Transrectal ultrasonography is less accurate in identifying transition zone tumors because of the mixed echogenicity of the transition zone, interference from prostatic calculi or calcified corpora amylacea, and poorer image resolution in this area. Studies evaluating the use of transrectal ultrasonography for early detection of prostate cancer generally have shown a twofold increase in the detection rate compared with digital rectal examination. However, the decreased morbidity and expense of transrectal prostate biopsy using an automatic gun device have increased the frequency of biopsy in ultrasound-examined patients compared with those historically evaluated by digital rectal examination. The increased detection rate may in part be a function of the increased use of biopsies, independent of other factors. Transrectal ultrasonography rarely detects cancer in patient with normal digital rectal examination and a normal serum prostate-specific antigen level. Transrectal ultrasonography may be capable of identifying early capsular penetration or seminal vesicle invasion in some patients with known prostate cancer. However, its superiority to digital rectal examination for this purpose has not been demonstrated unequivocally. Ultrasonography does allow directed biopsies of the seminal vesicles or other suspect areas, and this may be helpful in staging the disease. The use of transrectal ultrasonography in prostate cancer has evolved rapidly, and changes in technology antiquate reports within a few years.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2219575

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  6 in total

1.  Correlation of digital rectal examination, prostate specific antigen, and transrectal ultrasound in prostate carcinoma in African Americans.

Authors:  R I Sibley; A F Sibley
Journal:  J Natl Med Assoc       Date:  1997-05       Impact factor: 1.798

Review 2.  Radical prostatectomy and prostate cancer screening: the need for national audit and research.

Authors:  R R Hall
Journal:  Ann R Coll Surg Engl       Date:  1994-11       Impact factor: 1.891

3.  The combined value of mpUS and mpMRI-TRUS fusion for the diagnosis of clinically significant prostate cancer.

Authors:  Xin Zhang; Danyan Liang; Hua Hong
Journal:  Cancer Imaging       Date:  2022-10-18       Impact factor: 5.605

4.  The detection of prostatic carcinoma. 4- or 7-MHz transrectal ultrasonography?

Authors:  R Vleeming; J W Noordzij; T M de Reijke; K H Kurth
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

Review 5.  Imaging of prostate cancer.

Authors:  P L Choyke
Journal:  Abdom Imaging       Date:  1995 Nov-Dec

Review 6.  Diagnosis of prostate cancer via nanotechnological approach.

Authors:  Benedict J Kang; Minhong Jeun; Gun Hyuk Jang; Sang Hoon Song; In Gab Jeong; Choung-Soo Kim; Peter C Searson; Kwan Hyi Lee
Journal:  Int J Nanomedicine       Date:  2015-10-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.